Late-stage development, FDA marketing authorization, procurement, and stockpile of antibiotics for the treatment of drug-resistant secondary bacterial infections and/or the treatment or PEP of infections caused by biothreat pathogens.
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Department of Health and Human Services (HHS), specifically the Office of Assistant Secretary for Preparedness and Response (ASPR) and BARDA, has issued an Award Notice concerning the late-stage development, FDA marketing authorization, procurement, and stockpile of critical antibiotics. This initiative targets drug-resistant secondary bacterial infections and/or infections caused by biothreat pathogens.
Scope of Work
This notice pertains to efforts focused on:
- Late-stage development of antibiotics.
- Securing FDA marketing authorization for these antibiotics.
- Procurement of the developed antibiotics.
- Establishing a stockpile of antibiotics for the treatment of drug-resistant secondary bacterial infections and/or for the treatment or post-exposure prophylaxis (PEP) of infections caused by biothreat pathogens.
Contract & Timeline
- Type: Award Notice
- Set-Aside: None specified
- Notice Published Date: April 9, 2026
- Place of Performance: Florham Park, NJ, United States
- Product Service Code: AB11 (Community And Regional Development R&D Services; Community Development; Basic Research)
Additional Notes
For further information, interested parties may contact the primary contracting officer, Erin Greninger at erin.greninger@hhs.gov, or Audrey Glover at audrey.glover@hhs.gov.